2008Journal of Clinical RadiologyRequires access

Correlation Between Serum VEGF Level and CT Perfusion Parameters Before and After TACE in Patients with Hepatocellular Carcinoma

Zili Zhang

Open publisher page 0 citations

Abstract

Objective To investigate correlation between serum level of vascular endothelial growth factor(VEGF) and CT perfusion parameters (CTPP) before and after transcatheter hepatic arterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC).Materials and Methods The serum level of VEGF was measured and CT perfusion was performed 1 day before treatment and from 7 to 10 day after TACE in 17 patients with HCC.The values of hepatic blood flow (HBF),hepatic arterial fraction (HAF),hepatic arterial perfusion (HAP),portal vein perfusion(PVP) were calculated.Results There was statistically significant difference in HBF and HAP between that of pretreatment and posttreatment.There was positive correlation between the serum level of VEGF and HBF,HAF,and HAP.Conclusion The serum level of VEGF and CTPP could be helpful in the evaluation of the therapy effect of TACE.

About this research paper

What this paper is about

Objective To investigate correlation between serum level of vascular endothelial growth factor(VEGF) and CT perfusion parameters (CTPP) before and after transcatheter hepatic arterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC).Materials and Methods The serum level of VEGF was measured and CT perfusion was performed 1 day before treatment and from 7 to 10 day after TACE in 17 patients with HCC.The values of hepatic blood flow (HBF),hepatic arterial fraction (HAF),hepatic arterial perfusion (HAP),portal vein perfusion(PVP) were calculated.Results There was statistically significant difference in HBF and HAP between that of pretreatment and posttreatment.There was positive correlation between the serum level of VEGF and HBF,HAF,and HAP.Conclusion The serum level of VEGF and CTPP could be helpful in the evaluation of the therapy effect of TACE.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate correlation between serum level of vascular endothelial growth factor(VEGF) and CT perfusion parameters (CTPP) before and after transcatheter hepatic arterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC).Materials and Methods The serum level of VEGF was measured and CT perfusion was performed 1 day before treatment and from 7 to 10 day after TACE in 17 patients with HCC.The values of hepatic blood flow (HBF),hepatic arterial fraction (HAF),hepatic arterial perfusion (HAP),portal vein perfusion(PVP) were calculated.Results There was statistically significant difference in HBF and HAP between that of pretreatment and posttreatment.There was positive correlation between the serum level of VEGF and HBF,HAF,and HAP.Conclusion The serum level of VEGF and CTPP could be helpful in the evaluation of the therapy effect of TACE.

Key concepts: Medicine, Hepatocellular carcinoma, Perfusion, Transcatheter arterial chemoembolization, VEGF receptors, Perfusion scanning, Blood flow, Vascular endothelial growth factor

Related papers

Back to paper searchBrowse research topicsOriginal source
Correlation Between Serum VEGF Level and CT Perfusion Parameters Before and After TACE in Patients with Hepatocellular Carcinoma — Research Paper | ScholarLens